Johnson John H
SEC-identified person · CIK 1410781 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Lectec Corp /MN/ LECTEC | Director | filed 2021 - 2026 |
| Xeris Biopharma Holdings, Inc. XERS | Director | filed 2021 - 2026 |
| Verastem, Inc. VSTM | Director | filed 2020 - 2026 |
| Applied Therapeutics, Inc. APLT | Director · Executive Chairman | filed 2024 - 2024 |
| Strongbridge Biopharma plc SBBP | Director · Executive Chairman | filed 2018 - 2021 |
| Portola Pharmaceuticals INC PTLA | Director | filed 2014 - 2020 |
| Melinta Therapeutics, INC. /NEW/ MLNT | Director · Interim CEO | filed 2012 - 2019 |
| Ocugen, Inc. OCGN | Director | filed 2014 - 2018 |
| Sucampo Pharmaceuticals, Inc. SCMP | Director | filed 2014 - 2018 |
| Aveo Pharmaceuticals, INC. AVEO | Director | filed 2018 - 2018 |
| Dendreon Corp DNDNQ | Director · Pres & Chief Executive Officer | filed 2011 - 2014 |
| Tranzyme INC TZYM | Director | filed 2011 - 2012 |
| Savient Pharmaceuticals INC SVNT | Director · Chief Executive Officer | filed 2011 - 2012 |
| Lilly ELI & CO LLY | Sr. VP, Oncology Business Unit | filed 2009 - 2009 |
| Imclone Systems INC/DE IMCL | Director · CEO | filed 2007 - 2008 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.